All treatments
Treatment
ORENCIA 125 mg solution for injection in pre-filled syringe clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
ABATACEPT VERSUS TOCILIZUMAB BY SUBCUTANEOUS ADMINISTRATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN TARGETED TREATMENT INADEQUATE RESPONDER PATIENTS: A RANDOMIZED, OPENLABELED, SUPERIORITY TRIAL. -SUNSTAR-
This study compares two common medicines, Orencia and RoActemra, for adults with rheumatoid arthritis whose current treatments aren't working well enough. We want to see which one works better at reducing disease activity over six months.
For: Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.France - AuthorisedTherapeutic confirmatory (Phase III)
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis (SMART-JIA)
This study looks at different medicines for children and young people with JIA whose current treatment hasn't worked well enough. We want to find out which medicine best helps control their arthritis and reduces symptoms like pain and tiredness after 6 months.
For: Juvenile Idiopathic ArthritisItaly · Netherlands · Germany